{"disease":{"id":"idiopathic-inflammatory-myositis","name":"idiopathic inflammatory myositis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT05454527","title":"Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05879419","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2005,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT04637672","title":"Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)","phase":"","overall_status":"COMPLETED","enrollment_count":1273,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT00341679","title":"Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":719,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT05523167","title":"A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":265,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT06308978","title":"A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"Fate Therapeutics","has_results":false},{"nct_id":"NCT05669014","title":"A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05027152","title":"Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties","phase":"NA","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Federal University of Espirito Santo","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}